Annual Report 2024
Supported by the European Union
The power of sharing science
total financial contribution from the European Participating States by the end of 2024.
policy documents and guidelines for improved or extended use of existing medical interventions have cited EDCTP-funded research.
Stay connected
© European & Developing Countries Clinical Trials Partnership
The Hague, the Netherlands, July 2024
The EDCTP2 programme is supported under Horizon 2020, the European Union’s Framework Programme for Research and Innovation.
new or improved medical interventions were developed with contributions from EDCTP2.
The Global Health EDCTP3 programme continued to expand in 2024, with a boost to funding and new countries from Africa joining the EDCTP Association.
Global Health EDCTP3 in 2024
EDCTP continued to work with a wide range of partners in 2024, contributing to multiple global initiatives.
Strengthening partnerships
EDCTP2 has played a pivotal role in advancing clinical research in sub-Saharan Africa. In this Annual Report, we showcase recent examples.
Impact on health policy and practice
To track its progress and impact, EDCTP2 has set specific objectives and indicators. These indicators are crucial for monitoring how well the programme is achieving its goals and improving health outcomes in the region.
2014-2024
Towards EDCTP’s objectives
Strengthening the EDCTP Association
Achieving real impact
EDCTP2 has made significant contributions to enhancing research oversight systems in various African countries by funding multiple projects focused on research ethics committees and national regulatory agencies. Additionally, EDCTP's fellowship programme has empowered many recipients to advance in their careers, transitioning into independent researchers and emerging as leaders within their respective fields.
Collaboration
and capacity development
scroll down